This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Synthetic Biology Remains A Mystery

National survey finds three out of four adults have heard little or nothing about the emerging technology

WASHINGTON, March 20, 2013 /PRNewswire-USNewswire/ -- Despite advancements in the field of synthetic biology, three out of four adults surveyed in a national poll released today have heard "just a little" or "nothing at all" about the emerging technology, a level of awareness that has changed little since 2010.   

The national poll of more than 800 U.S. adults conducted by Hart Research Associates and the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars finds that there has only been a minor shift in public awareness of synthetic biology, an area of research focused on the design and construction of new biological parts and devices, or re-design of existing biological systems.

"Given these low levels of awareness about synthetic biology, attitudes about the technology are still largely unformed," said David Rejeski, director of the Synthetic Biology Project. "The information people receive about the science and its applications will be critical to how the public feels about this technology going forward."

As the public learns more about synthetic biology, there is greater movement toward concern about risk than optimism about benefits, the poll finds. After hearing some basic information about synthetic biology, 33 percent of adults express greater concern about risks from the technology, while 24 percent express more optimism about its benefits.

"This survey reveals the American public's nuanced and varied impressions of synthetic biology depending on the information provided and the application in question," said Abigail Davenport, a partner with Hart Research. "While the majority would like to see the science proceed, there are several findings that highlight the public's call for caution in moving ahead."

The public has divided opinions on the future of synthetic biology and the role of government regulation. While 61 percent think the science should move forward, one-third of respondents favor a ban "on synthetic biology research until we better understand its implications and risks."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs